Skip to main content

Manuel Glynias, Bill Blake, Ed Zander, Richard Woychik


NetGenics founder and former CEO Manuel Glynias has left Lion Biosciences, where he was serving as senior vice president for strategic planning following Lion’s acquisition of Netgenics in January.

A Lion spokesperson said Glynias’ departure was a “friendly and mutual decision.”


Bill Blake, formerly vice president of high performance technical computing at Compaq (now Hewlett-Packard), will be leaving the company at the end of June. He will join Framingham, Mass.-based database and data-mining startup Netezza as senior vice president of product development. “One of my goals is to help them bring their products to the bioinformatics marketplace,” said Blake of his new employer.

In May, Ed Zander, president and COO of Sun Microsystems, joined Netezza’s board of directors.


Richard Woychik, currently CSO of Hayward, Calif.-based Lynx Therapeutics, has been tapped as the new director of the Jackson Laboratory in Bar Harbor, Maine. He will assume his new role at the Jackson Lab in August and will continue to serve on Lynx’s board of directors.

Filed under

The Scan

Call to Look Again

More than a dozen researchers penned a letter in Science saying a previous investigation into the origin of SARS-CoV-2 did not give theories equal consideration.

Not Always Trusted

In a new poll, slightly more than half of US adults have a great deal or quite a lot of trust in the Centers for Disease Control and Prevention, the Hill reports.

Identified Decades Later

A genetic genealogy approach has identified "Christy Crystal Creek," the New York Times reports.

Science Papers Report on Splicing Enhancer, Point of Care Test for Sexual Transmitted Disease

In Science this week: a novel RNA structural element that acts as a splicing enhancer, and more.